Association between Lymphovascular Invasion and Recurrence in Patients with pT1N+ or pT2–3N0 Gastric Cancer: a Multi-institutional Dataset Analysis

다국어 초록 (Multilingual Abstract)

Purpose: Patients with pathological stage T1N+ or T2–3N0 gastric cancer may experience disease recurrence following curative gastrectomy. However, the current Japanese Gastric Cancer Treatment Guidelines do not recommend postoperative adjuvant chemotherapy for such patients. This study aimed to identify the prognostic factors for patients with pT1N+ or pT2–3N0 gastric cancer using a multi-institutional dataset.
Materials and Methods: We retrospectively analyzed the data obtained from 401 patients with pT1N+ or pT2–3N0 gastric cancer who underwent curative gastrectomy at 9 institutions between 2010 and 2014.
Results: Of the 401 patients assessed, 24 (6.0%) experienced postoperative disease recurrence. Multivariate analysis revealed that age ≥70 years (hazard ratio [HR], 2.62; 95% confidence interval [CI], 1.09–7.23; P=0.030) and lymphatic and/or venous invasion (lymphovascular invasion (LVI): HR, 7.88; 95% CI, 1.66–140.9; P=0.005) were independent prognostic factors for poor recurrence-free survival. There was no significant association between LVI and the site of initial recurrence.
Conclusions: LVI is an indicator of poor prognosis in patients with pT1N+ or pT2–3N0 gastric cancer.

참고문헌 (Reference)

1 Kanda M, "Tumor infiltrative pattern predicts sites of recurrence after curative gastrectomy for stages 2 and 3 gastric cancer" 23 : 1934-1940, 2016

2 Liu JY, "The prognosis role of AJCC/UICC 8th edition staging system in gastric cancer, a retrospective analysis" 10 : 292-303, 2018

3 Tokunaga M, "Prognostic factors for survival in patients with pT1 N+ or T2–3 N0 gastric cancer in Japan" 104 : 885-890, 2017

4 Kanda M, "Postoperative adjuvant chemotherapy with S-1 alters recurrence patterns and prognostic factors among patients with stage II/III gastric cancer : a propensity score matching analysis" 158 : 1573-1580, 2015

5 Shum H, "Multimodality management of resectable gastric cancer : a review" 6 : 393-402, 2014

6 Kanda M, "Multi-institutional analysis of the prognostic significance of postoperative complications after curative resection for gastric cancer" 8 : 5194-5201, 2019

7 Shen L, "Management of gastric cancer in Asia : resource-stratified guidelines" 14 : e535-e547, 2013

8 Dicken BJ, "Lymphovascular invasion is associated with poor survival in gastric cancer : an application of gene-expression and tissue array techniques" 243 : 64-73, 2006

9 del Casar JM, "Lymphatic and/or blood vessel invasion in gastric cancer : relationship with clinicopathological parameters, biological factors and prognostic significance" 134 : 153-161, 2008

10 Japanese Gastric Cancer Association, "Japanese gastric cancer treatment guidelines 2014(ver. 4)" 20 : 1-19, 2017

11 Japanese Gastric Cancer Association, "Japanese classification of gastric carcinoma : 3rd English edition" 14 : 101-112, 2011

12 Kunisaki C, "Impact of lymphovascular invasion in patients with stage I gastric cancer" 147 : 204-211, 2010

13 Du CY, "Impact of lymphatic and/or blood vessel invasion in stage II gastric cancer" 18 : 3610-3616, 2012

14 Van Cutsem E, "Gastric cancer" 388 : 2654-2664, 2016

15 Katai H, "Five-year survival analysis of surgically resected gastric cancer cases in Japan : a retrospective analysis of more than 100, 000 patients from the nationwide registry of the Japanese Gastric Cancer Association(2001–2007)" 21 : 144-154, 2018

16 Lu J, "Combination of lymphovascular invasion and the AJCC TNM staging system improves prediction of prognosis in N0 stage gastric cancer : results from a high-volume institution" 19 : 216-, 2019

17 Zhao B, "Clinicopathologic factors associated with recurrence and long-term survival in node-negative advanced gastric cancer patients" 111 : 111-120, 2019